ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhaled Nitric Oxide Delivery Device Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-35U10356
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Inhaled Nitric Oxide Delivery Device Market Research Report 2022
BUY CHAPTERS

Global Inhaled Nitric Oxide Delivery Device Market Research Report 2025

Code: QYRE-Auto-35U10356
Report
March 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
Getinge
VERO Biotech
Linde
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
Bellerophon Therapeutics
Praxair Technology，Inc
NU MED

Inhaled Nitric Oxide Delivery Device Market Size

The global market for Inhaled Nitric Oxide Delivery Device was valued at US$ 117 million in the year 2024 and is projected to reach a revised size of US$ 168 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Inhaled Nitric Oxide Delivery Device Market

Inhaled Nitric Oxide Delivery Device Market

North American market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inhaled Nitric Oxide Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inhaled Nitric Oxide Delivery Device include Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide Delivery Device.
The Inhaled Nitric Oxide Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhaled Nitric Oxide Delivery Device Market Report

Report Metric Details
Report Name Inhaled Nitric Oxide Delivery Device Market
Accounted market size in year US$ 117 million
Forecasted market size in 2031 US$ 168 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Inhaled Nitric Oxide Delivery Device for Children
  • Inhaled Nitric Oxide Delivery Device for Adults
Segment by Application
  • Hypoxic Respiratory Failure (HRF)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inhaled Nitric Oxide Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inhaled Nitric Oxide Delivery Device Market growing?

Ans: The Inhaled Nitric Oxide Delivery Device Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Inhaled Nitric Oxide Delivery Device Market size in 2031?

Ans: The Inhaled Nitric Oxide Delivery Device Market size in 2031 will be US$ 168 million.

Who are the main players in the Inhaled Nitric Oxide Delivery Device Market report?

Ans: The main players in the Inhaled Nitric Oxide Delivery Device Market are Mallinckrodt Pharmaceuticals, Getinge, Vero Biotech, LINDE, Beyond Air, Air Liquide Healthcare, Circassia Pharmaceuticals, NU MED, Bellerophon Therapeutics, Praxair Technology Inc.

What are the Application segmentation covered in the Inhaled Nitric Oxide Delivery Device Market report?

Ans: The Applications covered in the Inhaled Nitric Oxide Delivery Device Market report are Hypoxic Respiratory Failure (HRF), Acute Hypoxemic Respiratory Failure (AHRF), Chronic Obstructive Pulmonary Disease (COPD), Others

What are the Type segmentation covered in the Inhaled Nitric Oxide Delivery Device Market report?

Ans: The Types covered in the Inhaled Nitric Oxide Delivery Device Market report are Inhaled Nitric Oxide Delivery Device for Children, Inhaled Nitric Oxide Delivery Device for Adults

1 Inhaled Nitric Oxide Delivery Device Market Overview
1.1 Product Definition
1.2 Inhaled Nitric Oxide Delivery Device by Type
1.2.1 Global Inhaled Nitric Oxide Delivery Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inhaled Nitric Oxide Delivery Device for Children
1.2.3 Inhaled Nitric Oxide Delivery Device for Adults
1.3 Inhaled Nitric Oxide Delivery Device by Application
1.3.1 Global Inhaled Nitric Oxide Delivery Device Market Value by Application (2024 VS 2031)
1.3.2 Hypoxic Respiratory Failure (HRF)
1.3.3 Acute Hypoxemic Respiratory Failure (AHRF)
1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
1.3.5 Others
1.4 Global Inhaled Nitric Oxide Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Delivery Device Revenue 2020-2031
1.4.2 Global Inhaled Nitric Oxide Delivery Device Sales 2020-2031
1.4.3 Global Inhaled Nitric Oxide Delivery Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhaled Nitric Oxide Delivery Device Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhaled Nitric Oxide Delivery Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhaled Nitric Oxide Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Date of Enter into This Industry
2.8 Global Inhaled Nitric Oxide Delivery Device Market Competitive Situation and Trends
2.8.1 Global Inhaled Nitric Oxide Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhaled Nitric Oxide Delivery Device Players Market Share by Revenue
2.8.3 Global Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaled Nitric Oxide Delivery Device Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2020-2031
3.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2020-2025
3.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2026-2031
3.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2020-2031
3.3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2020-2025
3.3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2026-2031
3.4 North America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.4.1 North America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2031)
3.4.3 North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.5.1 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2031)
3.5.3 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2031)
3.7.3 Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2020-2031)
4.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2026-2031)
4.1.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2020-2031)
4.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2020-2031)
4.2.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2020-2025)
4.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2026-2031)
4.2.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2020-2031)
4.3 Global Inhaled Nitric Oxide Delivery Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2020-2031)
5.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2020-2025)
5.1.2 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2026-2031)
5.1.3 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2020-2031)
5.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2020-2031)
5.2.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2020-2025)
5.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2026-2031)
5.2.3 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2020-2031)
5.3 Global Inhaled Nitric Oxide Delivery Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Company Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Getinge
6.2.1 Getinge Company Information
6.2.2 Getinge Description and Business Overview
6.2.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
6.2.5 Getinge Recent Developments/Updates
6.3 Vero Biotech
6.3.1 Vero Biotech Company Information
6.3.2 Vero Biotech Description and Business Overview
6.3.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
6.3.5 Vero Biotech Recent Developments/Updates
6.4 LINDE
6.4.1 LINDE Company Information
6.4.2 LINDE Description and Business Overview
6.4.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
6.4.5 LINDE Recent Developments/Updates
6.5 Beyond Air
6.5.1 Beyond Air Company Information
6.5.2 Beyond Air Description and Business Overview
6.5.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
6.5.5 Beyond Air Recent Developments/Updates
6.6 Air Liquide Healthcare
6.6.1 Air Liquide Healthcare Company Information
6.6.2 Air Liquide Healthcare Description and Business Overview
6.6.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
6.6.5 Air Liquide Healthcare Recent Developments/Updates
6.7 Circassia Pharmaceuticals
6.7.1 Circassia Pharmaceuticals Company Information
6.7.2 Circassia Pharmaceuticals Description and Business Overview
6.7.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
6.7.5 Circassia Pharmaceuticals Recent Developments/Updates
6.8 NU MED
6.8.1 NU MED Company Information
6.8.2 NU MED Description and Business Overview
6.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
6.8.5 NU MED Recent Developments/Updates
6.9 Bellerophon Therapeutics
6.9.1 Bellerophon Therapeutics Company Information
6.9.2 Bellerophon Therapeutics Description and Business Overview
6.9.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
6.9.5 Bellerophon Therapeutics Recent Developments/Updates
6.10 Praxair Technology Inc.
6.10.1 Praxair Technology Inc. Company Information
6.10.2 Praxair Technology Inc. Description and Business Overview
6.10.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
6.10.5 Praxair Technology Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Nitric Oxide Delivery Device Industry Chain Analysis
7.2 Inhaled Nitric Oxide Delivery Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Nitric Oxide Delivery Device Production Mode & Process Analysis
7.4 Inhaled Nitric Oxide Delivery Device Sales and Marketing
7.4.1 Inhaled Nitric Oxide Delivery Device Sales Channels
7.4.2 Inhaled Nitric Oxide Delivery Device Distributors
7.5 Inhaled Nitric Oxide Delivery Device Customer Analysis
8 Inhaled Nitric Oxide Delivery Device Market Dynamics
8.1 Inhaled Nitric Oxide Delivery Device Industry Trends
8.2 Inhaled Nitric Oxide Delivery Device Market Drivers
8.3 Inhaled Nitric Oxide Delivery Device Market Challenges
8.4 Inhaled Nitric Oxide Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mallinckrodt Pharmaceuticals
Getinge
VERO Biotech
Linde
Beyond Air
Air Liquide Healthcare
Circassia Pharmaceuticals
Bellerophon Therapeutics
Praxair Technology，Inc
NU MED
List of Tables
 Table 1. Global Inhaled Nitric Oxide Delivery Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inhaled Nitric Oxide Delivery Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inhaled Nitric Oxide Delivery Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inhaled Nitric Oxide Delivery Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inhaled Nitric Oxide Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Product Type & Application
 Table 12. Global Key Manufacturers of Inhaled Nitric Oxide Delivery Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhaled Nitric Oxide Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide Delivery Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhaled Nitric Oxide Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2020-2025)
 Table 19. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2026-2031)
 Table 21. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Inhaled Nitric Oxide Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inhaled Nitric Oxide Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inhaled Nitric Oxide Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2020-2025)
 Table 53. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2026-2031)
 Table 54. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Inhaled Nitric Oxide Delivery Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2020-2025)
 Table 63. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2026-2031)
 Table 64. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Mallinckrodt Pharmaceuticals Company Information
 Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 72. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product
 Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 75. Getinge Company Information
 Table 76. Getinge Description and Business Overview
 Table 77. Getinge Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Getinge Inhaled Nitric Oxide Delivery Device Product
 Table 79. Getinge Recent Developments/Updates
 Table 80. Vero Biotech Company Information
 Table 81. Vero Biotech Description and Business Overview
 Table 82. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Vero Biotech Inhaled Nitric Oxide Delivery Device Product
 Table 84. Vero Biotech Recent Developments/Updates
 Table 85. LINDE Company Information
 Table 86. LINDE Description and Business Overview
 Table 87. LINDE Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. LINDE Inhaled Nitric Oxide Delivery Device Product
 Table 89. LINDE Recent Developments/Updates
 Table 90. Beyond Air Company Information
 Table 91. Beyond Air Description and Business Overview
 Table 92. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Beyond Air Inhaled Nitric Oxide Delivery Device Product
 Table 94. Beyond Air Recent Developments/Updates
 Table 95. Air Liquide Healthcare Company Information
 Table 96. Air Liquide Healthcare Description and Business Overview
 Table 97. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product
 Table 99. Air Liquide Healthcare Recent Developments/Updates
 Table 100. Circassia Pharmaceuticals Company Information
 Table 101. Circassia Pharmaceuticals Description and Business Overview
 Table 102. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product
 Table 104. Circassia Pharmaceuticals Recent Developments/Updates
 Table 105. NU MED Company Information
 Table 106. NU MED Description and Business Overview
 Table 107. NU MED Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. NU MED Inhaled Nitric Oxide Delivery Device Product
 Table 109. NU MED Recent Developments/Updates
 Table 110. Bellerophon Therapeutics Company Information
 Table 111. Bellerophon Therapeutics Description and Business Overview
 Table 112. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product
 Table 114. Bellerophon Therapeutics Recent Developments/Updates
 Table 115. Praxair Technology Inc. Company Information
 Table 116. Praxair Technology Inc. Description and Business Overview
 Table 117. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product
 Table 119. Praxair Technology Inc. Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Inhaled Nitric Oxide Delivery Device Distributors List
 Table 123. Inhaled Nitric Oxide Delivery Device Customers List
 Table 124. Inhaled Nitric Oxide Delivery Device Market Trends
 Table 125. Inhaled Nitric Oxide Delivery Device Market Drivers
 Table 126. Inhaled Nitric Oxide Delivery Device Market Challenges
 Table 127. Inhaled Nitric Oxide Delivery Device Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhaled Nitric Oxide Delivery Device
 Figure 2. Global Inhaled Nitric Oxide Delivery Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inhaled Nitric Oxide Delivery Device Market Share by Type: 2024 & 2031
 Figure 4. Inhaled Nitric Oxide Delivery Device for Children Product Picture
 Figure 5. Inhaled Nitric Oxide Delivery Device for Adults Product Picture
 Figure 6. Global Inhaled Nitric Oxide Delivery Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Inhaled Nitric Oxide Delivery Device Market Share by Application: 2024 & 2031
 Figure 8. Hypoxic Respiratory Failure (HRF)
 Figure 9. Acute Hypoxemic Respiratory Failure (AHRF)
 Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
 Figure 11. Others
 Figure 12. Global Inhaled Nitric Oxide Delivery Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Inhaled Nitric Oxide Delivery Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Inhaled Nitric Oxide Delivery Device Sales (2020-2031) & (K Units)
 Figure 15. Global Inhaled Nitric Oxide Delivery Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Inhaled Nitric Oxide Delivery Device Report Years Considered
 Figure 17. Inhaled Nitric Oxide Delivery Device Sales Share by Manufacturers in 2024
 Figure 18. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Inhaled Nitric Oxide Delivery Device Players: Market Share by Revenue in Inhaled Nitric Oxide Delivery Device in 2024
 Figure 20. Inhaled Nitric Oxide Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Inhaled Nitric Oxide Delivery Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Inhaled Nitric Oxide Delivery Device by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Inhaled Nitric Oxide Delivery Device by Type (2020-2031)
 Figure 57. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Inhaled Nitric Oxide Delivery Device by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Inhaled Nitric Oxide Delivery Device by Application (2020-2031)
 Figure 60. Global Inhaled Nitric Oxide Delivery Device Price (US$/Unit) by Application (2020-2031)
 Figure 61. Inhaled Nitric Oxide Delivery Device Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Inhaled Nitric Oxide Machines Market Research Report 2025
Nitric Oxide for Inhalation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inhaled NO Vasodilator Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Grade Nitric Oxide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nitric Oxide Asthma Testing Market Research Report 2024
Global Nitric Oxide Analyzer Market Research Report 2025
Global Nitric Oxide Therapy System Market Insights Forecast to 2030
Global Nitrous Oxide Delivery Systems Market Research Report 2024
Nasal Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inhalable Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Purity Nitric Oxide NO Market Research Report 2025
Delivery Device for Inhaled Nitric Oxide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oxygen and Aerosol Delivery Devices Market Research Report 2024
Global Inhaled Nitric Oxide NO Delivery Systems Market Insights Forecast to 2030
Delivery System for Inhaled Nitric Oxide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Delivery Machine for Inhaled Nitric Oxide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Portable Nasal High Flow Oxygen Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Devices for Inhaled Medications Market Research Report 2025
Non Invasive Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oxygen Inhaler Market Research Report 2024

RELATED REPORTS

Global Prototype Injection Molding Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28G14304
Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Blocked Isocyanate Crosslinkers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27T19056
Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Modified Phenolic Resins Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G19481
Wed May 21 00:00:00 UTC 2025

Add to Cart

Global Post-Emergent Herbicides Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36U19283
Wed May 21 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions
OSZAR »